CClinicalTrials.gg
Status unknownNCT01993342Updated Nov 25, 2013

Determination of Adipocytokine in Synovial Fluid of Osteoarthritis Patients

An observational study in Osteoarthritis, sponsored by Parc Taulí Hospital Universitari. Status unknown at 1 site in Spain. Open to participants aged 50 Years to 81 Years. Per ClinicalTrials.gov, last updated 2013-11-25.

Sponsored by Parc Taulí Hospital Universitari · Observational

The sponsor has not verified this record recently (last verified Nov 2013), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
35
Ages
50 Years to 81 Years
Sex
All
01

Study summary

The purpose of this study is to determine the concentration of different adipocytokine (adiponectin, leptin, resistin, visfatin, osteopontin) and an inflammation classic markers as Interleukine 1 beta, tumor necrosis alfa, interleukine 6 and high sensibility reactive c protein in the synovial fluid of knee osteoarthritis patients, and compare with the inflammation detected with ultrasonography evaluation of the joint. In last years, some studies appeared focusing on the role of adipocytokines in osteoarthritis and they correlated adipocytokines with cartilage degradation and x-ray degree; in our study we will focused in the importance of adipocytokines in the inflammatory changes more than in joint destruction.

02

Conditions studied

  • Osteoarthritis

Browse trials for

Keywords

  • adipocytokines
  • osteoarthritis
  • inflammation
  • ultrasonography
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's planned enrollment of 35 is below the median of 100 across 791 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Parc Taulí Hospital Universitari is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 81 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patient with knee osteoarthritis and synovial effusion who attende to a Rheumatologist unit for this problem. We made the visit and anonimously we kept the results of examination and ultrasonography in our database and we freezed synovial fluid. Now we will determine the adipocytokines and classic inflammatory parameters in this synovial fluid

Inclusion criteria

  • aged 50 to 81
  • primary osteoarthritis of the knee
  • synovial effusion in examination
  • patient who have the results in our database

Exclusion criteria

Exclusion Criteria:

  • any other rheumatic conditions as rheumatoid arthritis or another inflammatory disease
  • secondary knee osteoarthritis
  • history of knee surgery
  • any conditions that at investigator criteria exclude the patient from study procedures
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
35 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Inflammatory knee osteoarthritis

    We recruited patients with osteoarthritis and synovial effusion to diagnostic the effusion and to confirm that this this synovial fluid had mechanical characteristics. Now we are going to determine the adipocytokines and traditional parameters of inflammation in this synovial fluid to correlate it, and we will associate it with the ultrasound explanation of the knee that we have in our database.

    Other: arthrocentesis · Other: ultrasonography of the knee

Interventions

  • Otherarthrocentesis

    The made a diagnostic arthrocentesis to all patient we included

  • Otherultrasonography of the knee

    We explored the affected knee with an ultrasound explanation in order to describe inflammatory changes based on standard examination.

06

What researchers measure

Primary outcomes

  1. Determination of adipocytokine levels (adiponectin, leptin, resistin, visfatin, osteopontin) in synovial fluid

    We have all the synovial fluid freeze, so now we have to determine the levels of everyone.

    Time frame: We determine adipocytoquines in one month, all patients in the same determination kit

Secondary outcomes

  1. Knee inflammation parameters detected by ultrasonography

    We performed the ultrasonography evaluation at the same time than the visit were realized, and we have the results in a data base, so we will wait for the adipocytokine results and we will compare with ultrasound evaluation

    Time frame: three months

  2. To determine additional classic parameters of inflammation in synovial fluid as Interleukine 1 beta, Interleukine 6 and tumor necrosis factor alfa

    We will use classic inflammation parameters to compare with adipocytokine levels

    Time frame: We determine this inflammatory parameters in one month in all patient at the same time

07

Study locations

1 of 1 sites recruiting
  • Hospital Parc Tauli Sabadell
    Sabadell, Barcelona 08208, Spain
    • Joan Calvet, Dr · Contact · joan.calvet.fontova@gmail.com · 0034937231010
    • Cristobal Orellana, Dr · Contact · corellana@tauli.cat · 0034937231010
    • Joan Calvet, Dr · Principal investigator
    • Cristobal Orellana, Dr · Sub investigator
    • Maria Garcia-Manrique, Dra · Sub investigator
    • Noemi Navarro, Dra · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01993342
Lead sponsor
Parc Taulí Hospital Universitari
Responsible party
Joan Calvet Fontova (Dr, Parc Taulí Hospital Universitari) — Principal investigator
First posted
Nov 25, 2013
Start date
Oct 2013
Primary completion
Nov 2013 (estimated)
Completion
Mar 2014 (estimated)
Last update
Nov 25, 2013

Study contacts

Joan Calvet, Dr
Contact
joan.calvet.fontova@gmail.com
0034 937231010 ext. 24065
Cristobal Orellana, Dr
Contact
cristobalorellana1@gmail.com
0034 937231010 ext. 24059
Joan Calvet, Dr
principal investigator · Hospital Parc Tauli
Cristobal Orellana, Dr
study director · Hospital Parc Tauli

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion